NCT02343718 2023-08-04
Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
Canadian Cancer Trials Group
Phase 1 Completed
Canadian Cancer Trials Group
European Organisation for Research and Treatment of Cancer - EORTC